Stock report · Delisted · Nasdaq
Singular Genomics Systems Inc (OMIC)
20.01USD Delisted Final close · Feb 20, 2025
OMIC no longer trades. Singular Genomics Systems was delisted from the Nasdaq in February 2025.
All prices on this page are historical. The last trade was on February 20, 2025, at $20.01.
OMIC stock price history
Final trading statistics
- Final close
- $20.01
- Final trading day
- Feb 20, 2025
- Market cap at delisting
- $50.77M
- Shares outstanding
- 2.54M
- Final 52-week range
- $0.27 – $23.41
- Avg. volume (final 3 mo.)
- 13,609
- All-time high
- $935.10 · Jun 2021
- All-time low
- $5.65 · Sep 2024
- Return since IPO
- -97.6%
- Beta
- 1.83
- Book value / share
- $49.16
- Price / book
- 0.41
About Singular Genomics Systems Inc
Singular Genomics Systems was a life science technology company building next-generation sequencing and spatial multiomics tools for researchers and clinicians. Its G4 instrument and consumables supported uses such as single cell sequencing with max read kits, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing. Its PX instrument targeted single cell and spatial analysis.
The company was incorporated in 2016 and based in San Diego, California, and was taken private as of February 21, 2025. Its stock was delisted from the Nasdaq in February 2025, with the last trade on February 20, 2025 at $20.01.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- San Diego, CA
- Employees
- 255
- IPO date
- May 27, 2021
- Delisted
- February 20, 2025
- SEC CIK
- 1850906
Singular Genomics Systems financials before the delisting
The last 5 fiscal years Singular Genomics Systems reported as a public company, fiscal year ending December.
OMIC revenue and net income
OMIC earnings per share
OMIC annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $2.91M | −$94.8M | −$1.31 |
| FY2022 | $765.0K | −$88.3M | −$1.27 |
| FY2021 | $0.00 | −$98.9M | −$1.35 |
| FY2020 | $0.00 | −$28.7M | −$2.05 |
| FY2019 | $0.00 | −$12.3M | −$0.52 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Singular Genomics Systems stock FAQ
What happened to Singular Genomics Systems stock?
Singular Genomics Systems was delisted from the Nasdaq in February 2025. The final close was $20.01 on February 20, 2025.
Can I still buy OMIC stock?
No. OMIC is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on February 20, 2025.
What was the last price of OMIC?
OMIC last closed at $20.01 on February 20, 2025, which valued the company at about $50.77M.
How did Singular Genomics Systems do in its last full fiscal year?
In fiscal 2023, its last full year as a public company, Singular Genomics Systems reported revenue of $2.91M and net income of −$94.8M.
When did Singular Genomics Systems go public?
Singular Genomics Systems shares started trading on May 27, 2021.
OMIC no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.